Abstract
With newer antiretroviral therapies (ART), life expectancy of patients with HIV has increased. This led to an increased burden of cardiovascular diseases (CVD). To date, data on the race and gender-based trends and prevalence of various subtypes of CVD and CV mortality is scarce. Using the US
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
